TrialAtherosclerosis2014

Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia.

Feng Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.